These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 16714840)

  • 21. Plasma Bile Acids More Closely Align With Insulin Resistance, Visceral and Hepatic Adiposity Than Total Adiposity.
    Bishay RH; Tonks KT; George J; Samocha-Bonet D; Meyerowitz-Katz G; Chisholm DJ; James DE; Greenfield JR
    J Clin Endocrinol Metab; 2021 Mar; 106(3):e1131-e1139. PubMed ID: 33347566
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increased visceral adipose tissue mass is associated with increased C-reactive protein in patients with manifest vascular diseases.
    Faber DR; van der Graaf Y; Westerink J; Visseren FL
    Atherosclerosis; 2010 Sep; 212(1):274-80. PubMed ID: 20494358
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Is serum C-reactive protein concentration correlated with HbA1c and insulin resistance in Type 2 diabetic men with or without coronary heart disease?
    Bahceci M; Tuzcu A; Ogun C; Canoruc N; Iltimur K; Aslan C
    J Endocrinol Invest; 2005 Feb; 28(2):145-50. PubMed ID: 15887860
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Low Plasma Adiponectin Concentrations Predict Increases in Visceral Adiposity and Insulin Resistance.
    Han SJ; Boyko EJ; Fujimoto WY; Kahn SE; Leonetti DL
    J Clin Endocrinol Metab; 2017 Dec; 102(12):4626-4633. PubMed ID: 29029184
    [TBL] [Abstract][Full Text] [Related]  

  • 25. ADMA is a correlate of insulin resistance in early-stage diabetes independent of hs-CRP and body adiposity.
    Nakhjavani M; Karimi-Jafari H; Esteghamati A; Khalilzadeh O; Asgarani F; Ghadiri-Anari A
    Ann Endocrinol (Paris); 2010 Sep; 71(4):303-8. PubMed ID: 20434720
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inflammation, insulin resistance, and adiposity: a study of first-degree relatives of type 2 diabetic subjects.
    Kriketos AD; Greenfield JR; Peake PW; Furler SM; Denyer GS; Charlesworth JA; Campbell LV
    Diabetes Care; 2004 Aug; 27(8):2033-40. PubMed ID: 15277436
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hepatic fat content-independent association of the serum level of gamma-glutamyltransferase with visceral adiposity, but not subcutaneous adiposity.
    Iwasaki T; Yoneda M; Kawasaki S; Fujita K; Nakajima A; Terauchi Y
    Diabetes Res Clin Pract; 2008 Jan; 79(1):e13-4. PubMed ID: 17698237
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Relationship of serum novel adipokine chemerin levels with body composition, insulin resistance, dyslipidemia and diabesity in Saudi women.
    Habib SS; Eshki A; AlTassan B; Fatani D; Helmi H; AlSaif S
    Eur Rev Med Pharmacol Sci; 2017 Mar; 21(6):1296-1302. PubMed ID: 28387898
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Significant correlation between visceral adiposity and high-sensitivity C-reactive protein (hs-CRP) in Japanese subjects.
    Tsuriya D; Morita H; Morioka T; Takahashi N; Ito T; Oki Y; Nakamura H
    Intern Med; 2011; 50(22):2767-73. PubMed ID: 22082888
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Semiautomated Measure of Abdominal Adiposity Using Computed Tomography Scan Analysis.
    Srikumar T; Siegel EM; Gu Y; Balagurunathan Y; Garcia AL; Chen YA; Zhou JM; Zhao X; Gillies R; Clark W; Gamenthaler A; Choi J; Shibata D
    J Surg Res; 2019 May; 237():12-21. PubMed ID: 30694786
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Obesity is a major determinant of the association of C-reactive protein levels and the metabolic syndrome in type 2 diabetes.
    Kahn SE; Zinman B; Haffner SM; O'Neill MC; Kravitz BG; Yu D; Freed MI; Herman WH; Holman RR; Jones NP; Lachin JM; Viberti GC;
    Diabetes; 2006 Aug; 55(8):2357-64. PubMed ID: 16873701
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Luseogliflozin reduces epicardial fat accumulation in patients with type 2 diabetes: a pilot study.
    Bouchi R; Terashima M; Sasahara Y; Asakawa M; Fukuda T; Takeuchi T; Nakano Y; Murakami M; Minami I; Izumiyama H; Hashimoto K; Yoshimoto T; Ogawa Y
    Cardiovasc Diabetol; 2017 Mar; 16(1):32. PubMed ID: 28253918
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Correlation between Non-Alcoholic Fatty Liver Disease and Visceral Adipose Tissue in Non-Obese Chinese Adults: A CT Evaluation.
    Yu AH; Duan-Mu YY; Zhang Y; Wang L; Guo Z; Yu YQ; Wang YS; Cheng XG
    Korean J Radiol; 2018; 19(5):923-929. PubMed ID: 30174482
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Altered abdominal fat distribution and its association with the serum lipid profile in non-diabetic haemodialysis patients.
    Odamaki M; Furuya R; Ohkawa S; Yoneyama T; Nishikino M; Hishida A; Kumagai H
    Nephrol Dial Transplant; 1999 Oct; 14(10):2427-32. PubMed ID: 10528668
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Muscle adiposity and body fat distribution in type 1 and type 2 diabetes: varying relationships according to diabetes type.
    Dubé MC; Joanisse DR; Prud'homme D; Lemieux S; Bouchard C; Pérusse L; Lavoie C; Weisnagel SJ
    Int J Obes (Lond); 2006 Dec; 30(12):1721-8. PubMed ID: 16652137
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Atherogenic Index of Plasma is Associated with Body Fat Level in Type 2 Diabetes Mellitus Patients.
    Song P; Xu L; Xu J; Zhang HQ; Yu CX; Guan QB; Zhao M; Zhang X
    Curr Vasc Pharmacol; 2018; 16(6):589-595. PubMed ID: 29299987
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reduction of visceral fat by liraglutide is associated with ameliorations of hepatic steatosis, albuminuria, and micro-inflammation in type 2 diabetic patients with insulin treatment: a randomized control trial.
    Bouchi R; Nakano Y; Fukuda T; Takeuchi T; Murakami M; Minami I; Izumiyama H; Hashimoto K; Yoshimoto T; Ogawa Y
    Endocr J; 2017 Mar; 64(3):269-281. PubMed ID: 27916783
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diabetic retinopathy is associated with visceral fat accumulation in Japanese type 2 diabetes mellitus patients.
    Anan F; Masaki T; Ito Y; Eto T; Umeno Y; Eshima N; Saikawa T; Yoshimatsu H
    Metabolism; 2010 Mar; 59(3):314-9. PubMed ID: 20004426
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of subcutaneous and visceral fat adiposity in patients with colorectal cancer.
    Kim JM; Chung E; Cho ES; Lee JH; Shin SJ; Lee HS; Park EJ; Baik SH; Lee KY; Kang J
    Clin Nutr; 2021 Nov; 40(11):5631-5638. PubMed ID: 34662848
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association of C-reactive protein with early-stage carotid atherosclerosis in Japanese patients with early-state type 2 diabetes mellitus.
    Mita T; Watada H; Uchino H; Shimizu T; Hirose T; Tanaka Y; Kawamori R
    Endocr J; 2006 Oct; 53(5):693-8. PubMed ID: 16926521
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.